NFKB1 and neoplasm: Genetic and pharmacological inactivation of NF-κB-dependent cytokines reduces tumour growth due to activating other monogenic pathways in epithelial and cancer cells, including STAT3, extracellular signal-regulated kinase (ERK), JUN, and Tyr kinase receptor (TKR) [133, 145–148].